New SWITCH trial registered pitting apixaban against warfarin in HeartMate 3 patientsNov 5Weekly roundup, 3 itemsAbbott LaboratoriesapixabanUpdated
Pfizer registers four studies: elranatamab, berobenatide, tilrekimig, and completed etrasimod trialOct 23Weekly roundup, 14 itemsabrocitinibatirmociclibUpdated
Lilly posts two DC-806 Phase 1 DDI results; registers three new Phase 3 trialsOct 22Weekly roundup, 11 itemscetuximabdulaglutide
Lilly advances obesity and inflammation pipeline with new Phase 1 trials, Phase 2 updatesOct 9Weekly roundup, 10 itemsEli Lillyeloralintide
Merck registers Phase 2b trial of tulisokibart for noninfectious uveitisOct 9Weekly roundup, 8 itemsglycopyrrolateMerck & Co., Inc.
Insmed registers Phase 1 trial on brensocatib's effect on midazolam metabolismOct 5Trial updatebrensocatibInsmed Incorporated
GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerOct 2Weekly roundup, 11 itemscabotegravirganfeboroleUpdated
BeOne Medicines registers Phase 1 drug interaction trial for CDK4 inhibitor BGB-43395Sep 15Trial updateBeiGene
Novo Nordisk's two UBT251 drug interaction studies continue recruiting participantsJul 17Weekly roundup, 3 itemsNovo Nordisk A/SUBT251